Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment - Takeaways - MDSpire

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

  • By

  • Itamar Averbuch

  • Roi Tschernichovsky

  • Shlomit Yust-Katz

  • Ofer Rotem

  • Dror Limon

  • Noga Kurman

  • Oded Icht

  • Daniel Reinhorn

  • Mor Moskovitz

  • Ekaterina Hanovich

  • Alexandra Benouaich-Amiel

  • Tali Siegal

  • Alona Zer

  • Omer Gal

  • February 7, 2024

  • 0 min

Share

  • 1

    Brain metastasis (BM) occurs in 20-40% of metastatic cancer patients and is linked to severe neurological consequences.

  • 2

    Non-small cell lung cancer (NSCLC) patients with BM historically faced poor prognosis and were often excluded from clinical trials.

  • 3

    Recent advancements in targeted therapies and immunotherapy have improved survival rates for NSCLC patients with BM.

  • 4

    A study found that median survival for NSCLC patients with BM increased from 7 months to 15 months due to new treatment strategies.

  • 5

    The study aimed to compare survival outcomes of NSCLC patients with and without BM, challenging previous assumptions about prognosis.

Original Source(s)

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

  • by Itamar Averbuch, Roi Tschernichovsky, Shlomit Yust-Katz, Ofer Rotem, Dror Limon, Noga Kurman, Oded Icht, Daniel Reinhorn, Mor Moskovitz, Ekaterina Hanovich, Alexandra Benouaich-Amiel, Tali Siegal, Alona Zer, Omer Gal

  • February 7, 2024

Related Content

A pharmacodynamic study of rapid lactate metabolic modulation by intravenous L-arginine in brain metastases

Editorial: The role of circular RNAs and MicroRNAs in non-small cell lung cancer: from mechanisms to therapeutic potential

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases